Searchable abstracts of presentations at key conferences in endocrinology

ea0081p569 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Metabolic dysfunction–associated fatty liver disease and cardiovascular risk characterization

Perdomo Carolina M. , Nunez Jorge , Casajus Ana Ezponda , Mendoza Francisco J. , Aleman Gorka Bastarrika , Fruhbeck Gema , Escalada Javier

Objectives: Metabolic dysfunction–associated fatty liver disease (MAFLD) is a new nomenclature for fatty liver disease (FLD). The clinical impact of the change in nomenclature on the ability to identify individuals at risk for cardiovascular disease (CVD) has not yet been elucidated. The aim of this study is to describe the cardiovascular risk and subclinical CVD of the different MAFLD subtypes.Methods: Retrospective analysis of patients who attende...

ea0090p78 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Epicardial Fat, a cardiovascular risk factor with implications in kidney function

Perdomo Carolina M. , Martin-Calvo Nerea , Ezponda Casajus Ana , Mendoza Francisco J. , Bastarrika Aleman Gorka , de Assuncao Guilherme V. , Garcia-Fernandez Nuria , Fruhbeck Gema , Escalada Javier

Aim: Epicardial adipose tissue (EAT) has important physiologic functions, nonetheless, excessive EAT leads to a proinflammatory state with adverse effects on the myocardium. EAT has also been associated with adverse outcomes in chronic kidney disease (CKD) patients. We think that visceral adipose tissue (VAT) and organ-specific ectopic fat plays an important role in cardiorenal dysfunction. The aim of our study is to analyse the relationship between EAT and the risk of develop...

ea0056gp74 | Diabetes Complications | ECE2018

Is liver stiffness associated with diabetic complications in patients with type 2 diabetes and non-alcoholic fatty liver disease?

Perdomo Carolina M , Gargallo Javier , Llavero Maria , Garcia Marta , Bojorquez Alejandro , Inarrairaegui Mercedes , Herrero Jose I , Silva Camilo , Fruhbeck Gema , Salvador Javier , Escalada Javier

Aim: Non-alcoholic fatty liver disease (NAFLD) and type 2 Diabetes (T2D) are common conditions that frequently co-exist. Studies have shown an increase likelihood of micro and macrovascular complications in this population, as well, as an increased risk of developing more severe forms of liver disease. The aim of this study was to identify diabetic complications in patients with both diseases and search for an association with liver stiffness assessed by Liver Elastography (LE...

ea0056p595 | Obesity | ECE2018

The preoperative diagnosis of type 2 diabetes in the absence of antidiabetic treatment is associated with a worse performance after gastric-bypass compared to patients without diabetes

Gargallo Javier , Laguna Sara , Llavero Maria , Perdomo Carolina M , Valenti Victor , Escalada Javier , Gomez-Ambrosi Javier , Silva Camilo , Fruhbeck Gema , Salvador Javier

Objectives and methods: The mechanism that explains the different weight response to various treatments in obese type 2 diabetes (DM2) patients, compared to those without diabetes, is still unknown. In order to establish the weight response to Roux-en-Y Gastric Bypass (RYGB), 268 patients with morbid obesity (IMC 45.4±0.4 kg/m2) were classified by OGTT as having normal glucose tolerance (Grupo A. n=107), prediabetes (Grupo B. n=96) an...

ea0056p1048 | Thyroid (non-cancer) | ECE2018

Correlation of recommended diagnostic tools with pathological findings in the thyrotoxic patient

Perdomo Carolina M , Paricio Jose Joaquin , Llavero Maria , Gargallo Javier , Garcia Marta , Miralles Raquel , Morales Maria I , Alcalde Juan , Idoate Miguel Angel , Arbizu Javier , Galofre Juan C

Aim: A key diagnostic step to determine the cause of hyperthyroidism is the measurement of circulating thyroid-stimulating immunoglobulin (TSI). High levels are associated with GravesÂ’ disease (GD). A thyroid scintigraphy (TRS) is recommended when TSI is absent or its measurement unavailable, as TRS is capable of differentiating between GD (diffuse uptake) and toxic goitre (TG) (patchy uptake). Nevertheless, and while rarely necessary, histopathology remain the best metho...

ea0070aep403 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Epicardial fat accumulation and coronary artery calcification in non-alcoholic fatty liver disease

Perdomo Carolina M , Casajús Ana Ezponda , García Goñi Marta , Zapata Cardenas Juana K , Beloqui Ruiz Óscar , Fruhbeck Gema , Bastarrika Alemañ Gorka , Escalada Javier

Patients with non-alcoholic fatty liver disease (NAFLD) have a higher prevalence of cardiovascular disease, particularly patients with liver fibrosis. Studies have shown a relationship between epicardial fat/coronary calcium and myocardial ischemia.Aim: Quantify epicardial fat and coronary calcium assessed by computed tomography (CT) in patients with NAFLD. Additionally, determine whether patients with hepatic fibrosis quantitatively assessed by liver el...